Physician profile
Wesley F Frevert
NPI 1972822617
$4,967.43
in general payments reported to CMS, 2019-2025
13 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,952 · 2020: $11.89 · 2021: $1,697 · 2022: $1,013 · 2023: $48.24 · 2024: $58.92 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $293.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,907.77 | 2019-2025 | Bio4 |
| Arthrex, INC. | $1,422.13 | 2021-2022 | |
| Titan Surgical Group, LLC | $1,200.00 | 2021 | |
| Ermi LLC | $179.84 | 2019 | |
| Depuy Synthes Sales INC. | $45.65 | 2021-2023 | Monovisc, Peak, Orthovisc |
| Bioventus LLC | $45.31 | 2024-2025 | Durolane |
| Pacira Pharmaceuticals Incorporated | $33.01 | 2023 | Iovera, Zilretta |
| Medical Device Business Services, INC. | $32.51 | 2021 | |
| Encore Medical, LP | $26.22 | 2025 | Djo Surgical |
| Davol INC. | $25.06 | 2022 | |
| Medacta USA, INC. | $22.10 | 2024 | |
| Ferring Pharmaceuticals INC. | $15.94 | 2024 | Euflexxa |
| Horizon Therapeutics Plc | $11.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Frevert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.